Skip to main content
. 2016 Oct 12;7(46):76006–76020. doi: 10.18632/oncotarget.12579

Figure 5. IL-23 is required for stable expression of stem cell markers in CD133+ CSLCs.

Figure 5

A. A2780-derived CD133+ spheres were pretreated with DMSO or different concentrations of STA-5326 for 48h or untreated (Mock). The protein extracts were subjected to western blot analysis. Representative results of Nanog, Oct4, Sox2 and IL-23p40 expression are shown in each group. B. A2780-derived CD133+ spheres were pretreated with DMSO or different concentrations of STA-5326 for 48h. Immunofluorescence detection was performed in each group. Scale bars, 25μm.